Lochlan Fennell (@lochlanfennell) 's Twitter Profile
Lochlan Fennell

@lochlanfennell

Senior Lecturer at UniSC. Lab Head - Oncogenic Aging Lab, Views are my own, retweets not endorsements

ID: 899071135253315586

linkhttps://research.monash.edu/en/persons/lochlan-fennell calendar_today20-08-2017 00:50:37

390 Tweet

300 Followers

508 Following

Kelley Yan Lab Columbia (@columbiayan) 's Twitter Profile Photo

ICYMI: check out our lab's latest publication in Cell, where we discovered that FGFBP1 is a novel marker of stemness in the intestinal epithelium cell.com/cell/abstract/…

Lochlan Fennell (@lochlanfennell) 's Twitter Profile Photo

50% of EMCR’s in Australia report experiencing bullying, mostly by from senior colleagues. Funding bodies across the world #bullying policies for grantees with real sanctions. When will NHMRC, Australian Research Council their part to address this issue plaguing Australian #Academia? EMCR Forum

50% of EMCR’s in Australia report experiencing bullying, mostly by from senior colleagues. Funding bodies across the world #bullying policies for grantees with real sanctions. When will <a href="/nhmrc/">NHMRC</a>, <a href="/arc_gov_au/">Australian Research Council</a> their part to address this issue plaguing Australian #Academia? <a href="/EMCRForum/">EMCR Forum</a>
Hans Clevers (@hansclevers) 's Twitter Profile Photo

1) Excited to share a ms entitled: Integrin-activating Yersinia protein Invasin sustains long-term expansion of primary epithelial cells as 2D #organoid sheets. It describes an alternative to #Matrigel biorxiv.org/cgi/content/sh… A thread:

Lochlan Fennell (@lochlanfennell) 's Twitter Profile Photo

Another AGW comes to a close. A great week hearing about cutting edge clinical and translational gastroenterology and hepatology. One of the largest AGW’s to date and a testament to the great work going on around the country. #agw2024

Another AGW comes to a close. A great week hearing about cutting edge clinical and translational gastroenterology and hepatology. One of the largest AGW’s to date and a testament to the great work going on around the country. #agw2024
NHMRC (@nhmrc) 's Twitter Profile Photo

NHMRC is seeking feedback on assessment of research impact, updated score descriptors, and Investigator Grants emerging leadership category eligibility. Submit your views through NHMRC’s consultation hub by Wednesday 4 December 2024: ow.ly/Lrue50U4OaZ

NHMRC is seeking feedback on assessment of research impact, updated score descriptors, and Investigator Grants emerging leadership category eligibility. 

Submit your views through NHMRC’s consultation hub by Wednesday 4 December 2024: ow.ly/Lrue50U4OaZ
Shorts (@onlyshorts_) 's Twitter Profile Photo

Hey. On the 24th of November I'll be streaming for over 8 hours raising money for BowelCancerAustralia on my Twitch channel. We'll have Front Page for the 8 hours, so hopefully we can smash last year's sum of $3,000 USD. Hope you can stop by and hangout ❤️

Hey. 

On the 24th of November I'll be streaming for over 8 hours raising money for <a href="/BowelCancerAust/">BowelCancerAustralia</a> on my Twitch channel.

We'll have Front Page for the 8 hours, so hopefully we can smash last year's sum of $3,000 USD.

Hope you can stop by and hangout ❤️
BowelCancerAustralia (@bowelcanceraust) 's Twitter Profile Photo

Thank you to everyone that attended Bowel Cancer Australia’s inaugural Early-Onset Bowel Cancer Research Symposium.   In collaboration with A/Prof Daniel Buchanan, the inaugural symposium brought together experts in their field to help shape development of an Early-Onset Bowel

Thank you to everyone that attended Bowel Cancer Australia’s inaugural Early-Onset Bowel Cancer Research Symposium.
 
In collaboration with A/Prof Daniel Buchanan, the inaugural symposium brought together experts in their field to help shape development of an Early-Onset Bowel
Australian Research Council (@arc_gov_au) 's Twitter Profile Photo

Tomorrow, we’ll be announcing the outcomes of Discovery Projects 2025. All Lead Chief Investigators will receive a notification email to check RMS regarding applications. Stay tuned for an update.

Tuomas Tammela (@tuomastammela) 's Twitter Profile Photo

Several years in the making (and aging), Xueqian Zhuang 's study on aging is out today nature. She finds, surprisingly, that aging suppresses tumorigenesis and stemness in the lung by promoting a functional iron insufficiency in the alveolar epithelium. nature.com/articles/s4158…

Yin lab (@henryyin19) 's Twitter Profile Photo

As a PI, most of my lab skills have deteriorated. I barely know how to do anything in the lab, but I'm pretty good at multi-factor authentication, paperwork, electronic signatures... I also tell myself that I'm good at thinking about the big picture, whatever that means.

10 News First (@10newsfirst) 's Twitter Profile Photo

Bowel cancer diagnoses in young Australians are on the rise, with the risk of being diagnosed before the age of 40 more than doubling since 2000. For those aged 15 to 24, rates have skyrocketed by 266 per cent over the past three decades. Julien Wiggins, CEO of Bowel Cancer

Lochlan Fennell (@lochlanfennell) 's Twitter Profile Photo

I really hope that the Lancet got one of these letters and replied with the Wakefield-MMR article to answer how journals address misleading research…

Bishal Gyawali, MD, PhD, FASCO (@oncology_bg) 's Twitter Profile Photo

The most practice changing trial from #ASCO25 is now live on NEJM .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. Perfect case example of a #cancergroundshot trial.

The most practice changing trial from #ASCO25 is now live on <a href="/NEJM/">NEJM</a> .If this was a drug, this would be approved today. Globally relevant and low-cost intervention that is not only delaying relapse but actually improving survival. 
Perfect case example of a #cancergroundshot trial.
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.
Jiwoon Park (@jiwoonpark_) 's Twitter Profile Photo

The Spatial Atlas of Human Anatomy (SAHA) is out in Biorxiv! We present the first multi-organ, multimodal, subcellular-resolution spatial reference of healthy human tissues—a foundation for spatial biology, diagnostics, and translational research. 🧵[1/8] biorxiv.org/content/10.110…

BowelCancerAustralia (@bowelcanceraust) 's Twitter Profile Photo

Thanks to the generous support of people like you, Bowel Cancer Australia has so far raised more than $180,000 this Annual Giving Day. With a limited-time match opportunity expiring soon, we need your help to reach our $200,000 target by midnight tonight! + Latest Australian

Thanks to the generous support of people like you, Bowel Cancer Australia has so far raised more than $180,000 this Annual Giving Day.

With a limited-time match opportunity expiring soon, we need your help to reach our $200,000 target by midnight tonight!

+ Latest Australian